Alnylam: brands it owns and its ownership tree
Alnylam (NASDAQ: ALNY) is a publicly listed company headquartered in Cambridge, United States that owns 4 consumer brands.[1]
Alnylam is a US biotechnology company that develops RNA interference medicines. Its 2025 Form 10-K reports sales of Amvuttra, Onpattro, Givlaari and Oxlumo.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
subsidiaries recorded
Company facts
- Legal name
- Alnylam Pharmaceuticals, Inc.
- Headquarters
- 🇺🇸 Cambridge, United States
- Type
- publicly listed company · all publicly listed company owners
- Founded
- 2002
- Tickers
- NASDAQ: ALNY
- Identifiers
- SEC CIK 0001178670
- Last verified
- · 1 sources
Brands Alnylam owns
4 brands in 1 category.
Drug makers (4)
Full list of 4 brands with sources · Interactive ownership tree
Ownership structure
No company is recorded as controlling Alnylam.
Financials and filings
Alnylam financial history
Headline figures from Alnylam's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $492.9m to $3.71bn, an average of 49.8% a year (calculated).
| Fiscal year ended | Revenue | Operating income | Operating margin | Net income | Total assets | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|
| $3.71bn | $501.6m | 13.5% | $313.7m | $4.97bn | — | 10-K | |
| $2.25bn | $-176,885,000 | -7.9% | $-278,157,000 | $4.24bn | — | 10-K | |
| $1.83bn | $-282,175,000 | -15.4% | $-440,242,000 | $3.83bn | — | 10-K | |
| $1.04bn | $-785,072,000 | -75.7% | $-1,131,156,000 | $3.55bn | — | 10-K | |
| $844.3m | $-708,652,000 | -83.9% | $-852,824,000 | $3.64bn | — | 10-K | |
| $492.9m | $-828,438,000 | -168.1% | $-858,281,000 | $3.41bn | — | 10-K |
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Alnylam SEC filings
The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.
Annual reports
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
Proxy statements
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
Recent current and quarterly reports
| Filed | Form | What it declares |
|---|---|---|
| 8-K | Departure or appointment of directors or officers; Other events | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Departure or appointment of directors or officers; Results of a shareholder vote | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Departure or appointment of directors or officers | |
| 8-K | Results of operations and financial condition | |
| 8-K | Results of operations and financial condition | |
| 8-K | Other events | |
| 8-K | Departure or appointment of directors or officers | |
| 8-K | Results of operations and financial condition |
Alnylam in the global legal-entity registry
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
- Legal entity identifier (LEI)
- 529900S3ZI14OWRJII50
- Registered name
- Alnylam Pharmaceuticals, Inc. (US)
- Registration status
- Issued · record updated 2 July 2026
- Parent
- None named: it reports that it has no parent that consolidates its accounts.
- Retrieved
- · GLEIF record (JSON)
Frequently asked questions
What brands does Alnylam own?
Alnylam owns 4 consumer brands tracked here, including Amvuttra, Givlaari, Onpattro and Oxlumo.
Is Alnylam an American company?
Yes. Alnylam is headquartered in Cambridge, United States and was founded in 2002.
Who owns Alnylam?
Alnylam is a publicly listed company owned by its shareholders; it trades as ALNY on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Alnylam Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-12 — SEC EDGAR, SEC Form 10-K, published 12 February 2026; retrieved 8 November 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.